Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20250722066589N3Phase 2Completed
Phase 2, randomised, double-blind trial of dexmedetomidine in distal forearm fracture (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Block duration, Onset of block and 4 more. Started Aug 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20250722066589N3.